Novo Nordisk Launches Major Share Buyback

Novo Nordisk (NVO) has released an update.

Novo Nordisk A/S has announced a significant share repurchase program, with up to DKK 20 billion allocated for buybacks over a 12-month period starting February 2024. As part of this initiative, the company has undertaken a subsidiary program to repurchase DKK 2.4 billion worth of shares from August to November 2024. By late September 2024, Novo Nordisk has already acquired 12,671,184 B shares at an average price, contributing to their strategic treasury stock holdings.

For further insights into NVO stock, check out TipRanks’ Stock Analysis page.